Densitas

Halifax, Canada All Canada companies → — Founded 2011

Imaging AI Specialist Specialty-Focused AI

Oncology Radiology

Oncology AI Radiology & Imaging AI

Seed

Claim this company

Products

DM-Density

Densitas

Oncology AI

Densitas' DM-Density, now densitas densityai™, is an FDA-cleared AI software for automated and standardized breast density assessment from digital mammograms, aligning with ACR BI-RADS® Atlas 5th Edition.

densitas densityai

Densitas

Oncology AI

Densitas densityai™ is an AI-powered solution for automated and standardized breast density assessment from mammograms, aligning with ACR BI-RADS® guidelines to enhance consistency and support compliance in breast cancer screening.

Contact for pricing

See all 2 products →

About Densitas

Densitas is a global leader in artificial intelligence (AI) solutions specifically designed for mammography and breast cancer screening. Their primary goal is to enhance the quality and appropriateness of care while contributing to sustainable healthcare service delivery. The company’s core offering, intelliMammo™, is a comprehensive AI platform that includes several modules: densitas densityai™, densitas qualityai™, and densitas riskai™. These tools are designed to automate and standardize various aspects of mammography.

For physicians, Densitas’ solutions provide on-demand results at the point of care, as well as retrospective analytics at the clinic and health system level. densitas densityai™ offers automated, standardized, and reproducible breast density assessments aligned with ACR BI-RADS density scale assessments, which is crucial for consistent follow-up screening protocols. densitas qualityai™ evaluates image quality, ensuring compliance with standards like MQSA EQUIP and the Canadian Association of Radiologists Mammography Accreditation Program. Furthermore, densitas riskai™ provides breast cancer risk assessments based on image-derived factors and a limited number of clinical factors, aiding in the management of high-risk patients and supporting personalized screening and treatment protocols. The company aims to streamline workflows, improve operational efficiencies, and ensure compliance with national standards and guidelines.

Focus Areas

breast cancer screening mammography quality operational efficiency clinical decision support breast density assessment risk assessment workflow automation medical imaging AI healthcare analytics

Business Intelligence

Technology

AI-powered, machine learning algorithms, cloud-native (implied by marketplace integrations), PACS-centric integrations, DICOM input

What Physicians Need to Know

Breast Cancer Screening & Mammography Quality

Densitas provides AI solutions to improve mammography quality, focusing on continuous quality improvement tools for real-time and retrospective feedback to technologists. Their intelliMammo® Quality Improvement platform helps identify positioning gaps, standardize image quality assessments, and reduce unnecessary patient recalls due to poor image quality. This leads to higher mammography sensitivity and specificity.

Breast Density & Risk Assessment

Densitas offers automated and standardized breast density assessments using deep learning algorithms (intelliMammo® densityAI™ and intelliMammo® Breast Density) that align with ACR BI-RADS Atlas 5th edition guidance. These assessments are crucial inputs for personalized breast cancer risk models, helping identify higher-risk women who may benefit from supplemental screening. Their intelliMammo® High-Risk Patient Management platform provides precise, individualized breast cancer risk assessments and supports tailored patient care plans.

Operational Efficiencies & Workflow Optimization

Densitas' AI solutions aim to optimize operational efficiencies by digitizing workflows, automating compliance reporting, and reducing administrative burdens. This includes streamlining MQSA EQUIP reviews, cutting ACR accreditation image review time, and providing actionable insights for better reporting workflows. Their platforms help reduce clinical care team burnout by freeing up time for patient care.

Regulatory Compliance (FDA MQSA EQUIP, ACR Accreditation)

Densitas specializes in simplifying compliance with FDA MQSA EQUIP and ACR accreditation standards. Their intelliMammo® Quality Improvement solution streamlines EQUIP workflows, pre-populates them with algorithm-driven results, and generates on-demand comprehensive reports for inspectors. It also helps facilities prepare for ACR re-accreditation by filtering out lower-quality mammograms, reducing the workload for radiologists and technologists.

Technologist Training

The Densitas platform informs tailored technologist training protocols by identifying persistent positioning challenges and providing objective benchmarking across sites and staff. AI assigns a numeric score to unmet positioning criteria on every mammogram, highlighting areas where extra training or support is needed.

Personalized Breast Health & Population Health Management

Densitas enables personalized breast health through individualized risk stratification and tailored screening and treatment protocols. Their intelliMammo® High-Risk Patient Management platform provides a cohesive approach to patient and population health management throughout the breast cancer screening, diagnostic, prevention, and treatment pathways.

AI in Radiology

Densitas is a global leader in AI-driven solutions for breast cancer screening, leveraging deep learning and machine learning algorithms for various applications. Their AI is rigorously validated, vendor-neutral, and designed to deliver impact from image acquisition to interpretation and program operations.

Physician Tip

For physicians, Densitas' solutions offer greater diagnostic confidence through improved mammography quality and standardized breast density assessments. The AI-powered platforms streamline compliance with regulatory requirements (FDA MQSA EQUIP, ACR accreditation), reducing administrative burden and freeing up time for patient care. The personalized risk stratification and high-risk patient management tools enable tailored screening and treatment protocols, leading to earlier cancer detection and reduced unnecessary callbacks. The objective benchmarking and technologist training recommendations can also lead to more consistent image quality across the practice.

Densitas' intelliMammo® platform is designed for seamless integration with existing systems, including PACS and reporting workflows. They partner with companies like iCAD for a holistic breast health solution, Ikonopedia for structured reporting, and Blackford Analysis for access to a broad AI application portfolio. Their solutions are vendor-neutral and aim to fit within current breast screening workflows.

Products by Densitas

2 products in the directory

DM-Density

Densitas

Oncology AI

densitas densityai

Densitas

Oncology AI

Contact for pricing

What the Web Says

Densitas is a Halifax, Nova Scotia-based company that provides AI solutions for digital mammography, with its flagship product being "densityai" software. This software offers automated, standardized, and reproducible breast density assessments from standard DICOM mammograms, aligning with ACR BI-RADS classifications. The company emphasizes its rigorously validated, vendor-neutral AI that aims to improve quality and efficiency in breast cancer screening, addressing issues from acquisition to interpretation and program operations. Densitas' software has received FDA clearance and is available on the Nuance AI Marketplace.

Overall: Mixed

Strengths

Automated, standardized, and reproducible breast density assessments.
FDA-cleared software.
Utilizes routinely archived processed DICOM images.
Aims to improve workflow efficiency and compliance.
Designed to deliver impact from acquisition to interpretation to program operations.
Potential for earlier cancer detection and reduced unnecessary callbacks.

Limitations

No published pricing information; requires direct contact with the company.
No free plan or trial found.
Limited public reviews available on major platforms like G2, Glassdoor, and Capterra.
Vendor website was unreachable during some research.

Based on reviews from: Saaskart, Densitas (Official Website), AuntMinnie, Workopolis, SimplyHired, accessdata.fda.gov, BioSpace, YouTube, Reddit

Last updated: 2026-10-18

Videos

News, demos, and interviews about Densitas.

Loading videos...

Videos load interactively. If none appear, search YouTube for Densitas →

View all on YouTube

Press & Coverage

Imaging Technology News

Densitas Receives FDA Clearance for PACS-Centric Breast Density Software

Densitas Inc. received U.S. Food and Drug Administration (FDA) clearance for its DENSITAS|density automated breast density software, designed for PACS-centric integration.

2018-04

Dalhousie University - Department of Diagnostic Radiology

Associate Professor Mo Abdolell's company Densitas Receives 510(k) Clearance for Breast Density Software

Densitas Inc. received 510(k) clearance from the FDA for its machine-learning breast density assessment software, empowering radiologists with standardized, personalized, and automated density reports.

2018-03

BioSpace

Densitas Inc. Wins Major Procurement of Its AI-Powered Breast Density Software for DIMASOS Breast Screening Trial

Densitas' densitas densityai™ software was selected for deployment in up to 24 breast cancer screening clinics in Germany as part of the DIMASOS 2 Trial.

2019-09

PR Newswire

Densitas Joins Nuance AI Marketplace for Diagnostic Imaging To Deliver Breast Density Assessment

Densitas announced its FDA-cleared densitas densityai™ breast density assessment software would be available on the Nuance AI Marketplace, providing access to a large network of radiologists.

2019-10

Imaging Technology News

NorthShore University HealthSystem Adopts Groundbreaking densitas intelliMammo Artificial Intelligence Platform for Precision Breast Cancer Screening

NorthShore University HealthSystem deployed the densitas intelliMammo platform across its mammography facilities to automatically generate breast density, clinical image quality, and breast cancer risk assessments.

2020-11

G-MedTech

Densitas Launches intelliRisk Platform for Enhanced High-Risk Breast Cancer Patient Management

Densitas introduced intelliRisk™, a new platform designed to support high-risk breast cancer patient management, integrating with existing workflows for comprehensive care.

2024-11

PR Newswire

AI Meets QI: Densitas and TungstenQI Launch Joint Continuous Quality Improvement Initiative

Densitas partnered with TungstenQI Partners to integrate its intelliMammo® platform with TungstenQI's expertise for a continuous quality improvement initiative in mammography positioning.

2025-04

Intelerad

Densitas and Intelerad Forge Strategic Partnership to Advance Breast Cancer Screening with Innovative AI Technology

Densitas and Intelerad announced a strategic partnership to offer intelliMammo® to healthcare providers, aiming to enhance decision-making support and mammography quality improvement.

unknown

Frequently Asked Questions

How does Densitas' technology improve breast cancer screening and mammography quality?

Densitas leverages AI to automate objective mammography quality assessments, helping facilities meet and exceed quality standards. This includes evaluating positioning, compression, and other key metrics to reduce technical recalls and improve the accuracy of screening. By providing consistent, objective feedback, Densitas aims to enhance the overall quality of mammograms, leading to earlier and more accurate breast cancer detection.

What Densitas products are available to assist with breast density and breast cancer risk assessment, and how do they integrate into existing workflows?

Densitas offers AI solutions like Densitas Density and Densitas Risk for automated, standardized breast density assessment and personalized breast cancer risk evaluation. These products are designed to integrate seamlessly with existing PACS and EMR systems, providing automated reports and insights directly within the radiologist's workflow. This streamlines the assessment process, reduces variability, and supports personalized screening recommendations.

How can Densitas help my practice achieve operational efficiencies and workflow optimization in breast imaging?

Densitas' AI platform automates many manual tasks associated with mammography quality control, breast density assessment, and risk stratification, freeing up technologist and radiologist time. By providing real-time feedback and automated reporting, it helps optimize workflow, reduce errors, and improve overall efficiency in the breast imaging department. This can lead to reduced operational costs and improved patient throughput.

How does Densitas ensure compliance with regulatory standards like FDA MQSA EQUIP and ACR accreditation requirements?

Densitas' AI solutions are designed to align with and support compliance with regulatory standards such as FDA MQSA EQUIP and ACR accreditation. The platform provides objective, quantifiable data on mammography quality, which can be used for ongoing quality assurance and reporting. This helps facilities demonstrate adherence to regulatory guidelines and maintain accreditation.

What are Densitas' pricing models, and what kind of support and training can we expect for our staff?

Densitas typically offers subscription-based pricing models tailored to the size and needs of the facility. They provide comprehensive support, including implementation assistance, ongoing technical support, and training programs for technologists and radiologists. The goal is to ensure seamless integration and effective utilization of their AI solutions within your practice.

How does Densitas address concerns about AI in radiology, particularly regarding data privacy, accuracy, and the role of the radiologist?

Densitas prioritizes data privacy and security, adhering to industry standards and regulations. Their AI algorithms are rigorously validated to ensure accuracy and are designed to augment, not replace, the expertise of radiologists. The technology provides objective data and insights to support clinical decision-making, allowing radiologists to focus on complex cases and patient care.

What is Densitas' track record and company stability, and what partnerships do they have in the healthcare industry?

Densitas has established itself as a leader in AI-powered breast health solutions, with a growing presence in the market. While specific partnerships may vary, they often collaborate with leading healthcare institutions and technology providers to enhance their offerings and expand their reach. Information on their financial stability and specific partnerships can often be found through industry reports or direct inquiry.

Can Densitas' technology be used for population health management and personalized breast health strategies?

Yes, Densitas' AI platform can be instrumental in population health management by enabling standardized breast density and risk assessment across a large patient base. This allows for the identification of high-risk individuals who may benefit from personalized screening protocols. By providing actionable insights at scale, it supports the implementation of tailored breast health strategies for improved patient outcomes.

Related Companies

Suggest an Edit → | Report an issue